Dove Medical Press requires that the authors use the non-proprietary (generic) name of a drug throughout a manuscript whenever possible. The authors should give the chemical name or formula when a drug does not have a non-proprietary name. If this isn’t possible, for example for complex formulations, a drug can be identified by the proprietary (trade) name as appropriate and the non-proprietary name used subsequently. The active ingredients should be specified in the text after the first use of the proprietary name.
In the United States, check non-proprietary names in the American Drug Index, Merck Index, United States Pharmacopeia (USP), Physician’s Desk Reference, National Formulary, or United States Adopted Names (USAN), In the United Kingdom, the authors should refer to https://www.medicines.org.uk/emc/.
When the use of a proprietary name is necessary, the authors should place the non-proprietary name in parentheses immediately after the first mention of the proprietary name and use the non-proprietary name thereafter (once in the Abstract and once in the body of the manuscript is acceptable).
If an alternative non-proprietary name and a proprietary name are used, both may appear in parentheses at first mention.
When the salt is included in the non-proprietary name, it should only be given once.
The authors should capitalize proprietary names as appropriate and use the registered trademark symbol at first mention only.
Updated 10 September 2019